新光药业(300519) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the reporting period was CNY 84,146,045.75, an increase of 11.07% year-on-year [7]. - Net profit attributable to shareholders was CNY 29,203,464.99, reflecting a growth of 12.09% compared to the same period last year [7]. - The company reported a net profit of CNY 75,224,412.94 for the year-to-date, an increase of 8.63% compared to the same period last year [7]. - Total operating revenue for Q3 2020 was CNY 84,146,045.75, an increase of 11.4% compared to CNY 75,760,839.16 in the same period last year [30]. - Net profit for Q3 2020 reached CNY 29,203,464.99, representing a growth of 12.3% from CNY 26,054,265.33 in Q3 2019 [32]. - The total comprehensive income for Q3 2020 was CNY 29,126,044.43, an increase from CNY 25,756,453.19 in Q3 2019, representing a growth of 9.2% [33]. - The net profit for the third quarter of 2020 was CNY 75,224,412.94, representing an increase of 8.4% compared to CNY 69,251,237.85 in the same period last year [37]. - The total profit for the quarter was CNY 88,476,787.04, up from CNY 81,433,273.99, indicating a growth of 12.6% year-over-year [37]. Cash Flow - The net cash flow from operating activities was CNY 27,288,149.83, up 23.60% year-on-year [7]. - The cash flow from operating activities was CNY 74,699,705.67, an increase of 13.3% from CNY 65,949,698.46 in the same quarter last year [42]. - The company reported a net cash inflow from investing activities of CNY 119,655,517.25, significantly higher than CNY 12,624,812.32 in the previous year [42]. - The company experienced a decrease in cash flow from sales of goods and services, totaling CNY 189,271,335.72, down from CNY 194,905,933.34 [41]. - The company’s total cash outflow from financing activities was CNY 73,000,000.00, compared to CNY 49,000,000.00 in the previous year, indicating increased financial activity [42]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 860,143,537.17, a decrease of 0.11% compared to the end of the previous year [7]. - Total liabilities as of the end of Q3 2020 amounted to CNY 56,862,931.72, a decrease from CNY 61,420,403.74 at the end of the previous quarter [30]. - Total assets amounted to ¥861,130,616.44, with current assets at ¥698,407,571.08, and non-current assets at ¥162,723,045.36 [45]. - Total liabilities were ¥61,420,403.74, with current liabilities at ¥49,932,788.81 and non-current liabilities at ¥11,487,614.93 [47]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,846 [11]. - The largest shareholder, Wang Yuejun, holds 38.25% of the shares, totaling 61,200,000 shares [11]. Research and Development - R&D expenses decreased by 33.47% to ¥8,492,306.92 due to the impact of the pandemic [18]. - Research and development expenses for Q3 2020 were CNY 3,512,241.77, down from CNY 4,062,582.27, a reduction of 13.5% [30]. Investment Income - Investment income increased by 42.88% to ¥4,077,496.07, primarily from returns on financial products and dividends [18]. - The company reported an investment income of CNY 449,201.94 for Q3 2020, compared to CNY 570,263.44 in the previous year, reflecting a decline of 21.2% [32]. Changes in Accounting Standards - The company executed a new revenue recognition standard, resulting in a transfer of amounts from "prepayments" to "contract liabilities" [18]. - The company is implementing new revenue and leasing standards effective from 2020, impacting financial reporting [48]. - The report indicates that the third-quarter report was not audited [49]. Other Financial Metrics - Basic earnings per share for the reporting period were CNY 0.18, an increase of 12.50% compared to the same period last year [7]. - Basic and diluted earnings per share for the quarter were both CNY 0.47, up from CNY 0.43 in the previous year [38]. - The weighted average return on equity was 3.70%, an increase of 0.28% compared to the previous year [7]. - The company experienced a significant decrease in construction in progress by 62.18% to ¥5,652,316.88, due to equipment not meeting contractual requirements [18]. - The company reported a 72.27% increase in taxes payable to ¥13,205,028.02, reflecting an increase in taxable income [18].